MustGrow Biologics Corp. has announced the closure of its wholly-owned Canadian marketing and distribution business, NexusBioAg, effective April 15, 2026.

NexusBioAg, which had been reselling and distributing third-party agricultural products to Canadian farmers, operated in a highly competitive, low-margin market. The decision marks a strategic pivot for MustGrow as it shifts its focus to scaling production and expanding the reach of its proprietary mustard-derived organic biofertility product, TerraSante.

The closure of NexusBioAg will allow MustGrow to reallocate capital and resources toward meeting the growing demand for TerraSante in the U.S. market. The company stated in a news release that in 2025, demand for TerraSante from large-scale U.S. commercial farmers exceeded MustGrow’s production capacity, prompting the company to prioritize scaling inventory.

To support this effort, MustGrow secured $2 million in equity financing in January 2026, alongside a $2 million credit facility from CIBC, guaranteed by Canada’s Export Development Canada (EDC). These funds are being used to ramp up TerraSante production through international third-party manufacturers, enabling MustGrow to meet increasing demand without the need for costly in-house production facilities.

Currently approved for sale in six U.S. states, including California, Florida, and Oregon, TerraSante is certified under the Organic Materials Review Institute (OMRI) and California’s Organic Input Material (OIM) Program. MustGrow is also exploring global partnership opportunities to expand TerraSante’s footprint internationally.

The company says that TerraSante, a wettable powder derived from mustard plants, contains plant proteins and carbohydrates that nourish soil microbes, potentially improving soil microbiome health, nutrient availability, and water use efficiency.

RELATED
MustGrow Biologics moves to acquire NexusBioAg